Zhongchao Inc (NASDAQ:ZCMD) is trading higher in the pre-market session on Wednesday after partnering with Subsidiary of AbbVie Inc.
Major Trigger:
Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services
Key Highlights:
- ZCMD announced the cooperation in physician education with AbbVie Pharmaceutical Trading (Shanghai) Co., Ltd. (“AbbVie Shanghai”), a subsidiary of AbbVie Inc (NYSE: ABBV) (“AbbVie”).
- AbbVie is a research-based global biopharmaceutical company. Pursuant to an agreement to facilitate such cooperation, Zhongchao and AbbVie Shanghai will cooperate in, including but not limited to, developing the medical education contents and producing medical education courses.
Weiguang Yang, Chairman and Chief Executive Officer of Zhongchao, commented, “AbbVie is one of the top ten global research-oriented biopharmaceutical companies with numerous innovations in the core field of immunology, oncology, neuroscience, and Allergan Aesthetics.
In recent years, AbbVie has introduced more and more innovative therapies and drugs to the Chinese market, benefitting Chinese patients. We are honored to cooperate with AbbVie Shanghai to promote the development of medical education.”
Market Reaction
As of 7:57, ZCMD is trading at $1.84, up 4.55%. So far more than 43K shares have exchanged hands.
 Stock Gains Momentum){kind=link}